3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
15
Breast Neoplasms
13
Leukemia, Myeloid, Acute
11
Carcinoma, Non-Small-Cell Lung
11
Glioblastoma
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
8
Brain Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Mantle-Cell
7
Leukemia
7
Multiple Myeloma
6
Hodgkin Disease
6
Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, T-Cell, Cutaneous
5
Lung Neoplasms
5
Gliosarcoma
5
Congenital Abnormalities
5
Breast Neoplasms, Male
5
Recurrence
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Immunoblastic Lymphadenopathy
4
Interventions
Sunitinib
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangioblastoma
×
Vorinostat
×
Clear all
No trials found.